EU Approves Long-Lasting HIV Prevention Drug Lenacapavir

The EU has approved a new drug called lenacapavir to prevent HIV.

This drug is an injection that people get only twice a year, which is much less often than daily pills or other injections.

Studies show it works very well to stop HIV from spreading.

The World Health Organization also suggests offering it to people at risk.

While this is good news, some worry the drug won't be available everywhere, especially in areas where the number of cases is going up.

The company making the drug plans to sell cheaper versions in some poorer countries to help more people get it.